The Covid-19 pandemic has laid bare Europe’s vulnerability to drug-supply disruption. Still, it remains by far the world leader in pharmaceutical products.
Academic rigor, journalistic flair
Articles on Bayer
Displaying all articles
Bayer, the new owner of Monsanto, will need to up its PR efforts, in the wake of last week’s legal ruling on glyphosate weedkillers.
The global food system has been operating in post-truth mode for decades.
Two large multinational pharmaceutical companies are fighting for patents and monopoly pricing in Indian courts. The outcomes of the cases – involving Novartis and Bayer – are likely to determine the country’s…
Top contributors
-
Associate Professor Politics and Policy Studies, Deakin University
-
Senior Lecturer, Department of Media and Communications, Faculty of Arts and Social Sciences, University of Sydney
-
Director, Agri-Food Analytics Lab, Professor in Food Distribution and Policy, Dalhousie University
-
Économiste, rédactrice en chef du Panorama et coordinatrice des Profils du CEPII, CEPII
-
Chercheur associé, CEPII
-
Économiste, CEPII
-
Chercheur associé au CEPII, Maître de conférences, Université Paris Dauphine – PSL
